blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2925737

EP2925737 - TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.04.2018
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  12.05.2017
FormerGrant of patent is intended
Status updated on  11.01.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Zafgen, Inc.
175 Portland Street
4th Floor
Boston, MA 02114 / US
[2016/07]
Former [2015/41]For all designated states
Zafgen, Inc.
One Broadway, 8th Floor
Cambridge, MA 02142 / US
Inventor(s)01 / PALLIN, Thomas, David
8/9 Spire Green Centre
Flex Meadow
Harlow Essex CM19 5TR / GB
02 / CRAMP, Susan, Mary
8/9 Spire Green Centre
Flex Meadow
Harlow Essex CM19 5TR / GB
03 / DYKE, Hazel, Joan
8/9 Spire Green Centre
Flex Meadow
Harlow Essex CM19 5TR / GB
04 / ZAHLER, Robert
5 East Welling Avenue
Pennington, NJ 08534 / US
 [2015/41]
Representative(s)Harris, Jennifer Lucy
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2015/41]Harris, Jennifer Lucy
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date13792204.305.11.2013
[2015/41]
WO2013US68492
Priority number, dateUS201261722449P05.11.2012         Original published format: US 201261722449 P
[2015/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014071369
Date:08.05.2014
Language:EN
[2014/19]
Type: A1 Application with search report 
No.:EP2925737
Date:07.10.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 08.05.2014 takes the place of the publication of the European patent application.
[2015/41]
Type: B1 Patent specification 
No.:EP2925737
Date:14.06.2017
Language:EN
[2017/24]
Search report(s)International search report - published on:EP08.05.2014
ClassificationIPC:C07D405/12, C07D451/02, C07D453/02, C07D487/04, C07D311/94
[2017/03]
CPC:
C07D311/94 (EP,CN,US); A61P3/04 (EP); A61P43/00 (EP);
A61P9/00 (EP); C07D405/12 (EP,CN,US); C07D451/02 (EP,US);
C07D453/02 (EP,CN,US); C07D487/04 (EP,US) (-)
Former IPC [2015/41]C07D311/94, A61K31/353, A61P3/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/41]
Extension statesBA05.06.2015
ME05.06.2015
TitleGerman:TRICYCLISCHE VERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG UND/ODER KONTROLLE VON ADIPOSITAS[2015/41]
English:TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY[2015/41]
French:COMPOSÉS TRICYCLIQUES À UTILISER DANS LE TRAITEMENT ET/OU LA LUTTE CONTRE L'OBÉSITÉ[2015/41]
Entry into regional phase05.06.2015National basic fee paid 
05.06.2015Designation fee(s) paid 
05.06.2015Examination fee paid 
Examination procedure05.06.2015Examination requested  [2015/41]
18.02.2016Amendment by applicant (claims and/or description)
20.04.2016Despatch of a communication from the examining division (Time limit: M06)
25.10.2016Reply to a communication from the examining division
12.01.2017Communication of intention to grant the patent
08.05.2017Fee for grant paid
08.05.2017Fee for publishing/printing paid
08.05.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.04.2016
Opposition(s)15.03.2018No opposition filed within time limit [2018/21]
Fees paidRenewal fee
30.11.2015Renewal fee patent year 03
28.11.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.11.2013
AL14.06.2017
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
TR14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
[2020/34]
Former [2020/28]HU05.11.2013
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
TR14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2020/15]HU05.11.2013
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
TR14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2019/51]HU05.11.2013
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2019/47]HU05.11.2013
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2019/31]HU05.11.2013
AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2018/50]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
BE30.11.2017
Former [2018/43]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
MT05.11.2017
Former [2018/40]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU05.11.2017
Former [2018/33]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/21]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/11]AT14.06.2017
CZ14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
IT14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/10]AT14.06.2017
CZ14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2018/09]EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/52]FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/50]FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/49]FI14.06.2017
HR14.06.2017
LT14.06.2017
NO14.09.2017
GR15.09.2017
Cited inInternational search[A]WO2012012642  (ZAFGEN CORP [US], et al) [A] 1-13 * example 20; claims 1, 18-30 *;
 [XP]WO2012154676  (ZAFGEN CORP [US], et al) [XP] 1-13 * claims 1, 32-41 *
by applicantUS2004167128
    - O'BRIEN ET AL., AMER J SURGERY, (2002), vol. 184, pages 4S - 8S
    - HILL ET AL., SCIENCE, (1998), vol. 280, page 1371
    - WARDER ET AL., J PROTEOME RES, (2008), vol. 7, page 4807
    - WANG ET AL., CANCER RES., (2003), vol. 63, page 7861
    - ZHANG ET AL., J. BIOMED. SCI., (2002), vol. 9, page 34
    - RUPNICK ET AL., PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, page 10730
    - RAUTIO, KUMPULAINEN ET AL., NATURE REVIEWS DRUG DISCOVERY, (2008), vol. 7, page 255
    - SIMPLICIO ET AL., MOLECULES, (2008), vol. 13, page 519
    - MIYAURA, SUZUKI, CHEM. REV., (1995), vol. 95, page 2457
    - SUZUKI, MODEM ARENE CHEMISTRY, (2002), pages 53 - 106
    - SMITH, MARCH, March's Advanced Organic Chemistry, WILEY, (2001), pages 931 - 932
    - DE SOUZA, CURRENT ORGANIC SYNTHESIS, (2006), vol. 3, no. 3, pages 313 - 326
    - MARSHALL, CHEMTRACTS, (2000), vol. 13, no. 4, pages 219 - 222
    - ASTRUP, A, PUB HEALTH NUTR, (2001), vol. 4, pages 499 - 515
    - CARR ET AL., THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, (2004), vol. 89, no. 6, pages 2601 - 2607
    - ECKEL, CIRCULATION, (1997), vol. 96, pages 3248 - 3250
    - WONG ET AL., NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, (2007), vol. 4, pages 436 - 443
    - YUSEF ET AL., LANCET, (2005), vol. 366, no. 9497, pages 1640 - 1649
    - SUK ET AL., STROKE, (2003), vol. 34, pages 1586 - 1592
    - STEIN ET AL., THE AMERICAN JOURNAL OF MEDICINE, (2005), vol. 18, no. 9, pages 978 - 980
    - SZTRYMF ET AL., REV PNEUMOL CLIN, (2002), vol. 58, no. 2, pages 104 - 10
    - ELAMIN, CHEST, (2004), vol. 125, pages 1972 - 1974
    - KESSLER ET AL., EUR RESPIR J, (1996), vol. 9, pages 787 - 794
    - TOLMAN ET AL., THER CLIN RISK MANAG, (2007), vol. 6, pages 1153 - 1163
    - VAN SAASE, J RHEUMATOL, (1988), vol. 15, no. 7, pages 1152 - 1158
    - PRADER-WILLI SYNDROME, "polycystic ovary syndrome, have been linked to being overweight or obese. Cassidy", JOURNAL OF MEDICAL GENETICS, (1997), vol. 34, pages 917 - 923
    - HOEGER, OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, (2001), vol. 28, no. 1, pages 85 - 97
    - LARSEN ET AL., INT J OBES (LOND, (2007), vol. 8, pages 1189 - 1198
    - CHUNG ET AL., EUR UROL, (1999), vol. 36, no. 1, pages 68 - 70
    - PASQUALI ET AL., HUM REPROD, (1997), vol. 1, pages 82 - 87
    - WEISS ET AL., AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (2004), vol. 190, no. 4, pages 1091 - 1097
    - DIXSON ET AL., ARCH INTERN MED, (2003), vol. 163, pages 2058 - 2065
    - SIMON ET AL., ARCHIVES OF GENERAL PSYCHIATRY, (2006), vol. 63, no. 7, pages 824 - 830
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.